Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.05 (-4.59%)
Close on Nov 17, 2026Market cap $9.37MP/E –Yield –
Lisata Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lisata Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.32M. For fiscal 2025 it was -$15.95M. The highest annual figure on record is -$8.48M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.95M | – |
| FY2024 | Dec 31, 2024 | -$19.36M | – |
| FY2023 | Dec 31, 2023 | -$20.03M | – |
| FY2022 | Dec 31, 2022 | -$21.17M | – |
| FY2021 | Dec 31, 2021 | -$22.25M | – |
| FY2020 | Dec 31, 2020 | -$8.82M | – |
| FY2019 | Dec 31, 2019 | -$18.88M | – |
| FY2018 | Dec 31, 2018 | -$19.99M | – |
| FY2017 | Dec 31, 2017 | -$20.88M | – |
| FY2016 | Dec 31, 2016 | -$23.67M | – |
| FY2015 | Dec 31, 2015 | -$39.26M | – |
| FY2014 | Dec 31, 2014 | -$46.90M | – |
| FY2013 | Dec 31, 2013 | -$27.10M | – |
| FY2012 | Dec 31, 2012 | -$13.85M | – |
| FY2011 | Dec 31, 2011 | -$20.93M | – |
| FY2010 | Dec 31, 2010 | -$8.48M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.08M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.34M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.96M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.52M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.07M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.18M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.47M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.06M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.60M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.04M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.63M | -202.8% |
| Q1 FY2021 | Mar 31, 2021 | -$7.98M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.57M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.52M | – |
| Q2 FY2020 | Jun 30, 2020 | $4.50M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.24M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.22M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.46M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.72M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.49M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.04M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.89M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.30M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.97M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$488.49K | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.38M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.72M | – |
See a number that looks wrong?